crypto currency values Featured snippets

The Beijing Municipal Science and Technology Commission and Zhongguancun Management Committee investigated the brain-computer interface technology under Chengyitong. Recently, Li Junnan, Minister of the Frontier Department of Medical Center of Beijing Science and Technology Commission and Zhongguancun Management Committee, and Zheng Meng, Deputy Director of Daxing District Science and Technology Commission, and his party went to Beijing Naolin Technology Co., Ltd., a subsidiary of Chengyitong, to have in-depth exchanges on further promoting the development and application of brain-computer interface technology. According to reports, at present, the company has made a series of important technological breakthroughs, and has completed the trial production of three prototypes of nerve rehabilitation products based on brain-computer interface technology, namely, products based on visual evoked potential paradigm-brain-computer interface cognitive rehabilitation system, brain-computer interface hand function rehabilitation system, and innovative mixed paradigm products based on visual reinforcement of motor imagination-brain-computer interface upper and lower limb active and passive rehabilitation system.Huasu Technology: Contemporary Amperex Technology Co., Limited is actively docking BMS-related products in the energy storage field. Huasu Technology said on the interactive platform on December 10 that the company and Contemporary Amperex Technology Co., Limited are actively docking BMS-related products in the energy storage field, and there is still uncertainty about whether they can reach cooperation in the later stage. Companies in the field of electric vehicle BMS have not been involved yet.China's trade account in November was 692.8 billion yuan, with the previous value of 679.1 billion yuan.

Significant progress in domestic growth hormone! Jichuan Pharmaceutical Co., Ltd. and Tianjing Biological Co., Ltd. announced that the listing application of Etan long-acting growth hormone was accepted, with a height of 10.76 cm a year, which made significant progress in domestic growth hormone. Today, Tianjing Bio and Jichuan Pharmaceutical jointly announced that the application for marketing biological products of Etan long-acting recombinant human growth hormone injection (hereinafter referred to as "Etan long-acting growth hormone") for treating children's growth hormone deficiency (PGHD) has been accepted by NMPA. As the first and only long-acting growth hormone with fusion protein in the domestic application stage and listed products, this innovative therapy is expected to provide safe, effective and convenient treatment options for children with growth hormone deficiency. Etan long-acting growth hormone adopts innovative hyFc® fusion protein technology, which greatly improves the stability and half-life of the drug by combining human growth hormone with specially designed human immunoglobulin. This patented technology not only ensures the biological activity of growth hormone, but also realizes the long-acting function of growth hormone in the body, thus making Ethan the first fusion protein long-acting growth hormone to be administered once a week.Analyst: The market from September 24th to October 8th may not be interpreted in the short term. Today, the A-share market opened, and the three major indexes all opened sharply higher. The Shanghai Composite Index opened 2.58%, the Shenzhen Component Index opened 3.66%, the Growth Enterprise Market Index opened 4.88%, and the Shanghai and Shenzhen stock markets opened less than 50 stocks. In addition, Hong Kong's Hang Seng Index opened up 3.21%, and the Hang Seng Technology Index rose 4.24%. So, how to interpret the future market? Analysts believe that the market from September 24 to October 8 may not be interpreted in the short term. After all, the chip pressure still exists, but the bull market atmosphere may last longer and spread more widely. From the short-term perspective, three major signals have also appeared. First of all, the one ETF Southern China A-Share CSI 500, which was first opened in the peripheral Japanese stock market, fell slightly after it surged. Yesterday, the Nasdaq China Jinlong Index also fell back in the late session, and after the A50 opened in the morning, it also fell slightly, indicating that the funds may be more rational. Second, before the surge, the intensity of foreign ambush was not as great as last time. Yesterday's data showed that the global position of Long onlys has returned to the level of June. The low option trading volume of FXI/KWEB also shows the slight degree of macro investors' positions. It may also mean that the follow-up potential is also relatively large; Third, foreign investors have less doubts about the market this time than last time. After the last surge, foreign investment was still generally not optimistic, but the degree of optimism was significantly enhanced this time. (Broker China)Navigation warning! In the sea shooting test in the southern part of the Yellow Sea, Lianyungang Maritime Safety Administration issued a navigation warning. From 8: 00 to 14: 00 on December 11, some sea areas in the southern part of the Yellow Sea were fired with live ammunition, and it was forbidden to enter. (Website of China Maritime Safety Administration)

AI application direction rose and strengthened. Many stocks such as Hanwang Technology rose and strengthened, while Hanwang Technology, Aofei Entertainment, Tianyue Digital, Bona Film and Jincai Internet rose, while Haitian Ruisheng, Iflytek, Fushi Holdings and Sanliuling followed suit.Shibor reported 1.4700% overnight, down 4.6 basis points; In 7 days, shibor reported 1.7840%, up 4.8 basis points; In three months, shibor reported 1.7480%, down 0.5 basis point.China's total export in November was 2,221.72 billion yuan, with the previous value of 2,189.92 billion yuan. China's total import volume in November was 1,528.92 billion yuan, with the previous value of 1,510.82 billion yuan.